Cowealth Medical China Co.,Ltd. (SHA:603122)
China
· Delayed Price · Currency is CNY 15.25
-0.30 (-1.93%)
At close: Apr 29, 2026
Cowealth Medical China Revenue
Cowealth Medical China had revenue of 154.33M CNY in the quarter ending March 31, 2026, a decrease of -12.18%. This brings the company's revenue in the last twelve months to 656.38M, down -25.09% year-over-year. In the year 2025, Cowealth Medical China had annual revenue of 677.79M, down -27.83%.
Revenue (ttm)
656.38M
Revenue Growth
-25.09%
P/S Ratio
9.43
Revenue / Employee
3.23M
Employees
203
Market Cap
6.19B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.20B |
| Shanghai Runda Medical Technology | 7.00B |
| SMO ClinPlus CO.,LTD. | 842.50M |
| Thalys Medical Technology Group | 971.32M |
| Shanghai Labway Clinical Laboratory | 1.45B |
| Guangdong Hybribio Biotech | 691.16M |